Compounds > irinotecan

Page last updated: 2024-08-24

irinotecan and HIV Coinfection

irinotecan has been researched along with HIV Coinfection in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Kwenda, S; Mathew, JM; Mavri-Damelin, D; Mpangase, PT; Ramsay, M; Sengupta, D	1
Bearz, A; Berretta, M; Berretta, S; Fisichella, R; Lleshi, A; Nasti, G; Simonelli, C; Tirelli, U; Zanet, E	1
Ieki, R; Iguchi, M; Kato, T; Okamura, T; Ota, T; Saito, E; Shibuya, M; Yuasa, K	1
di Gennaro, G; Schioppa, O; Simonelli, C; Tirelli, U; Vaccher, E	1
Cattarossi, G; Corona, G; Sartor, I; Toffoli, G; Vaccher, E	1
Corona, G; Innocenti, F; Sandron, S; Sartor, I; Tirelli, U; Toffoli, G; Vaccher, E	1

Trials

1 trial(s) available for irinotecan and HIV Coinfection

Article	Year
Evidence of activity of Irinotecan in patients with advanced AIDS-related Kaposi's sarcoma. AIDS (London, England), 2005, Nov-04, Volume: 19, Issue:16 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Camptothecin; Hematologic Diseases; HIV Infections; Humans; Irinotecan; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome	2005

Other Studies

5 other study(ies) available for irinotecan and HIV Coinfection

Article	Year
Pharmacogenomics, 2021, Volume: 22, Issue:15 Topics: Anti-HIV Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Computational Biology; Genotype; Glucuronosyltransferase; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Irinotecan; Liver; Oxazines; Piperazines; Pyridones; Quality Control; South Africa; Treatment Outcome; Up-Regulation	2021
Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer. Onkologie, 2008, Volume: 31, Issue:7 Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Camptothecin; Colorectal Neoplasms; Fluorouracil; HIV Infections; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Treatment Outcome	2008
A long-term survival case of small cell lung cancer in an HIV-infected patient. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:6 Topics: Alkynes; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Benzoxazines; Camptothecin; Carbamates; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Administration Schedule; Furans; HIV Infections; HIV Long-Term Survivors; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Oxazines; Ritonavir; Sulfonamides; Tomography, X-Ray Computed	2005
Potential hazard of pharmacokinetic interactions between lopinavir-ritonavir protease inhibitors and irinotecan. AIDS (London, England), 2005, Nov-18, Volume: 19, Issue:17 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Camptothecin; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Irinotecan; Lopinavir; Male; Pyrimidinones; Ritonavir; Sarcoma, Kaposi	2005
Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Area Under Curve; Camptothecin; Drug Therapy, Combination; HIV Infections; Humans; Irinotecan; Lamivudine; Lopinavir; Male; Middle Aged; Organophosphonates; Pyrimidinones; Ritonavir; Sarcoma, Kaposi; Tenofovir; White People	2008